Global DNA Methylation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for DNA Methylation Market is presumed to reach the market size of nearly USD 20.23 BN by 2030 from USD 5.46 BN in 2022 with a CAGR of 17.79% under the study period 2023 - 2030.

DNA Methylation is a process in the mammalian genome that involves adding the methyl group to the C5 position of cytosine to form 5-methylcytosine. This mechanism regulates gene expression by luring proteins involved in gene repression or obstructing transcription factors' ability to bind with DNA. DNA Methylation primarily plays a significant role in the repression of repetitive element transcription and transposition, as well as genome imprinting.

Market Dynamics:

The growing prevalence of cancer is anticipated to drive the market growth of DNA methylation. DNA methylation is also used to diagnose several illnesses, such as neurological disorders, cardiovascular disorders, autoimmune diseases, and imprinting disorders, further fueling the market growth of DNA methylation. Additionally, the rising healthcare expenditure for diagnosis and treatment drives the market growth of DNA methylation. Declining treatment costs and simplified product approval processes will grow the DNA methylation market. Furthermore, substantial direct government investments continue to create new growth opportunities for research and development projects which will further propel the market growth of DNA methylation.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dna methylation. The growth and trends of dna methylation industry provide a holistic approach to this study.

Market Segmentation:

This section of the dna methylation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Others

By Product

Consumables
Kits & Reagents
Enzymes
Instruments & Software

By Application

Gene Therapy
Clinical Research
Diagnostics
Others

By End-Use

Hospital & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Research & Academia

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the DNA Methylation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the dna methylation market include New England Biolabs, Sysmex Corporation, Abcam plc., F. Hoffmann-La Roche Ltd., Diagenode Diagnostics S.A., Thermo-Fisher Scientific Inc., Agilent Technologies Inc., BioRad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Active Motif, Inc., Illumina Inc., EpiGentek Group Inc., Pacific Biosciences Inc., New England Biolabs Inc., Merck KGaA, Zymo Research Corporation, PerkinElmer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110174

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DNA METHYLATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL DNA METHYLATION MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Polymerase Chain Reaction (PCR) Historic and Forecast Sales by Regions
6.5 Microarray Historic and Forecast Sales by Regions
6.6 Sequencing Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL DNA METHYLATION MARKET ANALYSIS BY PRODUCT

7.1 Overview by Product
7.2 Historical and Forecast Data
7.3 Analysis by Product
7.4 Consumables Historic and Forecast Sales by Regions
7.5 Kits & Reagents Historic and Forecast Sales by Regions
7.6 Enzymes Historic and Forecast Sales by Regions
7.7 Instruments & Software Historic and Forecast Sales by Regions

8 . GLOBAL DNA METHYLATION MARKET ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Gene Therapy Historic and Forecast Sales by Regions
8.5 Clinical Research Historic and Forecast Sales by Regions
8.6 Diagnostics Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL DNA METHYLATION MARKET ANALYSIS BY END-USE

9.1 Overview by End-use
9.2 Historical and Forecast Data
9.3 Analysis by End-use
9.4 Hospital & Diagnostic Laboratories Historic and Forecast Sales by Regions
9.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
9.6 Research & Academia Historic and Forecast Sales by Regions

10 . GLOBAL DNA METHYLATION MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE DNA METHYLATION COMPANIES

11.1. Dna Methylation Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF DNA METHYLATION INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. New England Biolabs
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Sysmex Corporation
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Abcam plc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. F. Hoffmann-La Roche Ltd.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Diagenode Diagnostics S.A.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Thermo-Fisher Scientific Inc.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Agilent Technologies Inc.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. BioRad Laboratories Inc.
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Exact Sciences Corporation
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. QIAGEN N.V.
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Active Motif Inc.
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. Illumina Inc.
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. EpiGentek Group Inc.
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. Pacific Biosciences Inc.
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. New England Biolabs Inc.
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. Merck KGaA
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. Zymo Research Corporation
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments
12.20. PerkinElmer Inc.
- 12.20.1. Company Overview
- 12.20.2. Company Revenue
- 12.20.3. Products
- 12.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies